Natural killer cells and cytotoxic T lymphocytes are required to clear solid tumor in a patient-derived xenograft

Duy T. Le(Baylor College of Medicine), Silke Paust(Scripps Research Institute), Bryan M. Burt(Baylor College of Medicine), Shawn Abeynaike(Scripps Research Institute), Cristina Zalfa(University of California San Diego), Tridu R. Huynh(Scripps Research Institute), Farrah Kheradmand(Baylor College of Medicine), John J. Tyner(Scripps Clinic), George Van Buren(Baylor College of Medicine), Rana Nikzad(Scripps Research Institute)
JCI Insight
June 3, 2021
Cited by 19


Related Papers